{"id":"https://openalex.org/W2147396454","doi":"https://doi.org/10.2174/1871520611313050013","title":"Unified Multi-target Approach for the Rational in silico Design of Anti-bladder Cancer Agents","display_name":"Unified Multi-target Approach for the Rational in silico Design of Anti-bladder Cancer Agents","publication_year":2013,"publication_date":"2013-05-01","ids":{"openalex":"https://openalex.org/W2147396454","doi":"https://doi.org/10.2174/1871520611313050013","mag":"2147396454","pmid":"https://pubmed.ncbi.nlm.nih.gov/23272967"},"language":"en","primary_location":{"id":"doi:10.2174/1871520611313050013","doi":"https://doi.org/10.2174/1871520611313050013","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1871520611313050013","pdf_url":null,"source":{"id":"https://openalex.org/S159246083","display_name":"Anti-Cancer Agents in Medicinal Chemistry","issn_l":"1568-0118","issn":["1568-0118","1871-5206","1875-5968","1875-5992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Agents in Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077424712","display_name":"Alejandro Speck\u2010Planche","orcid":"https://orcid.org/0000-0002-9544-9016","observed_orcids":["https://orcid.org/0000-0002-9544-9016"]},"institutions":[{"id":"https://openalex.org/I182534213","display_name":"Universidade do Porto","ror":"https://ror.org/043pwc612","country_code":"PT","type":"education","lineage":["https://openalex.org/I182534213"]},{"id":"https://openalex.org/I4210138594","display_name":"Rede de Qu\u00edmica e Tecnologia","ror":"https://ror.org/04j14t006","country_code":"PT","type":"nonprofit","lineage":["https://openalex.org/I4210138594"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Alejandro Speck- Planche","raw_affiliation_strings":["REQUIMTE/Department of Chemistry and Biochemistry University of Porto, 4169-007 Porto Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"REQUIMTE/Department of Chemistry and Biochemistry University of Porto, 4169-007 Porto Portugal","institution_ids":["https://openalex.org/I182534213","https://openalex.org/I4210138594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032399671","display_name":"Valeria V. Kleandrova","orcid":"https://orcid.org/0000-0002-1928-853X","observed_orcids":["https://orcid.org/0000-0002-1928-853X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Valeria V. Kleandrova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055771112","display_name":"Feng Luan","orcid":"https://orcid.org/0000-0003-0254-2973","observed_orcids":["https://orcid.org/0000-0003-0254-2973"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Feng Luan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5031900984","display_name":"M. Nat\u00e1lia D. S. Cordeiro","orcid":"https://orcid.org/0000-0003-3375-8670","observed_orcids":["https://orcid.org/0000-0003-3375-8670"]},"institutions":[{"id":"https://openalex.org/I182534213","display_name":"Universidade do Porto","ror":"https://ror.org/043pwc612","country_code":"PT","type":"education","lineage":["https://openalex.org/I182534213"]},{"id":"https://openalex.org/I4210138594","display_name":"Rede de Qu\u00edmica e Tecnologia","ror":"https://ror.org/04j14t006","country_code":"PT","type":"nonprofit","lineage":["https://openalex.org/I4210138594"]}],"countries":["PT"],"is_corresponding":true,"raw_author_name":"M. N. D. S. Cordeiro","raw_affiliation_strings":["REQUIMTE/Department of Chemistry and Biochemistry, University of Porto, 4169-007 Porto, Portugal.,Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"REQUIMTE/Department of Chemistry and Biochemistry, University of Porto, 4169-007 Porto, Portugal.,Portugal","institution_ids":["https://openalex.org/I182534213","https://openalex.org/I4210138594"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5031900984"],"corresponding_institution_ids":["https://openalex.org/I182534213","https://openalex.org/I4210138594"],"apc_list":null,"apc_paid":null,"fwci":2.5327,"has_fulltext":false,"cited_by_count":45,"citation_normalized_percentile":{"value":0.90373726,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"13","issue":"5","first_page":"791","last_page":"800"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11948","display_name":"Machine Learning in Materials Science","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.75},{"id":"https://openalex.org/keywords/multi-target-qsar","display_name":"multi-target QSAR","score":0.9390000104904175},{"id":"https://openalex.org/keywords/computer-aided-drug-design","display_name":"computer-aided drug design","score":0.796999990940094},{"id":"https://openalex.org/keywords/bladder-cancer-cell-lines","display_name":"bladder cancer cell lines","score":0.7749999761581421},{"id":"https://openalex.org/keywords/2d-molecular-descriptors","display_name":"2D molecular descriptors","score":0.859000027179718},{"id":"https://openalex.org/keywords/linear-discriminant-analysis","display_name":"linear discriminant analysis","score":0.8410000205039978},{"id":"https://openalex.org/keywords/neural-network","display_name":"artificial neural networks","score":0.9959999918937683},{"id":"https://openalex.org/keywords/virtual-screening","display_name":"virtual screening","score":0.35199999809265137}],"concepts":[{"id":"https://openalex.org/C164126121","wikidata":"https://www.wikidata.org/wiki/Q766383","display_name":"Quantitative structure\u2013activity relationship","level":2,"score":0.8978446125984192},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.7842040061950684},{"id":"https://openalex.org/C69738355","wikidata":"https://www.wikidata.org/wiki/Q1228929","display_name":"Linear discriminant analysis","level":2,"score":0.6604512929916382},{"id":"https://openalex.org/C53105671","wikidata":"https://www.wikidata.org/wiki/Q14777816","display_name":"Rational design","level":2,"score":0.539881706237793},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.470082551240921},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.3865090310573578},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.36540958285331726},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.22683998942375183},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14230450987815857},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D021281","descriptor_name":"Quantitative Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/1871520611313050013","doi":"https://doi.org/10.2174/1871520611313050013","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1871520611313050013","pdf_url":null,"source":{"id":"https://openalex.org/S159246083","display_name":"Anti-Cancer Agents in Medicinal Chemistry","issn_l":"1568-0118","issn":["1568-0118","1871-5206","1875-5968","1875-5992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Agents in Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:23272967","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23272967","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer agents in medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W1535279744","https://openalex.org/W1875906722","https://openalex.org/W1971842146","https://openalex.org/W1976272764","https://openalex.org/W1986170246","https://openalex.org/W1989555764","https://openalex.org/W1993770244","https://openalex.org/W1996405164","https://openalex.org/W2002503642","https://openalex.org/W2003831539","https://openalex.org/W2005596839","https://openalex.org/W2010901209","https://openalex.org/W2011729909","https://openalex.org/W2013504674","https://openalex.org/W2017013630","https://openalex.org/W2019193650","https://openalex.org/W2029492694","https://openalex.org/W2032411331","https://openalex.org/W2033525264","https://openalex.org/W2047986674","https://openalex.org/W2049012837","https://openalex.org/W2050884752","https://openalex.org/W2051068375","https://openalex.org/W2059282893","https://openalex.org/W2059449978","https://openalex.org/W2077251274","https://openalex.org/W2087726892","https://openalex.org/W2091269995","https://openalex.org/W2093090488","https://openalex.org/W2094494364","https://openalex.org/W2098840560","https://openalex.org/W2121875517","https://openalex.org/W2122814955","https://openalex.org/W2125696977","https://openalex.org/W2132168836","https://openalex.org/W2133644521","https://openalex.org/W2135711893","https://openalex.org/W2140328654","https://openalex.org/W2141007879","https://openalex.org/W2162559284","https://openalex.org/W2165436089","https://openalex.org/W2171260305","https://openalex.org/W2312603069","https://openalex.org/W2331903788","https://openalex.org/W2415368926","https://openalex.org/W2496509757"],"related_works":["https://openalex.org/W2011729909","https://openalex.org/W2331903788","https://openalex.org/W2894098565","https://openalex.org/W2909219231","https://openalex.org/W2469096481","https://openalex.org/W2101059404","https://openalex.org/W2125696977","https://openalex.org/W2121875517","https://openalex.org/W7082645173","https://openalex.org/W2516686615"],"abstract_inverted_index":{"Bladder":[0],"cancer":[1],"(BLC)":[2],"is":[3,11,68],"a":[4,47,60,102],"very":[5,61],"dangerous":[6],"and":[7,32,49,104,167,172,192,201],"common":[8],"disease":[9],"which":[10,181],"characterized":[12],"by":[13,93],"an":[14],"uncontrolled":[15],"growth":[16],"of":[17,25,40,77,107,120,165,188],"the":[18,23,53,89,118,144,186],"urinary":[19],"bladder":[20],"cells.":[21],"In":[22],"field":[24],"chemotherapy,":[26],"many":[27],"compounds":[28,78,121,169],"have":[29],"been":[30],"synthesized":[31],"evaluated":[33],"as":[34,122,198],"anti-BLC":[35,43,75,123,203],"agents.":[36,204],"The":[37,130],"future":[38],"design":[39,55],"more":[41,162],"potent":[42,200],"drugs":[44],"depends":[45],"on":[46,135],"rigorous":[48],"rational":[50],"discovery,":[51],"where":[52],"computer-aided":[54],"(CADD)":[56],"methodologies":[57],"should":[58],"play":[59],"important":[62],"role.":[63],"However,":[64],"until":[65],"now,":[66],"there":[67],"no":[69],"CADD":[70],"methodology":[71],"able":[72],"to":[73],"predict":[74],"activity":[76],"versus":[79],"different":[80,178],"BLC":[81,127,191],"cell":[82,128],"lines.":[83,129],"We":[84,175],"report":[85],"in":[86,170],"this":[87],"work":[88],"first":[90,131],"unified":[91],"approach":[92],"exploring":[94],"Quantitative-":[95],"Structure":[96],"Activity":[97],"Relationship":[98],"(QSAR)":[99],"studies":[100],"using":[101,149],"large":[103],"heterogeneous":[105],"database":[106],"compounds.":[108],"Here,":[109],"we":[110,193],"constructed":[111],"two":[112],"multi-target":[113],"(mt)":[114],"QSAR":[115],"models":[116,159],"for":[117,185],"classification":[119],"agents":[124],"against":[125,190],"four":[126],"model":[132,146],"was":[133,147],"based":[134],"linear":[136],"discriminant":[137],"analysis":[138],"(mt-QSAR-LDA)":[139],"employing":[140],"fragment-based":[141],"descriptors":[142],"while":[143],"second":[145],"obtained":[148],"artificial":[150],"neural":[151],"networks":[152],"(mt-QSAR-ANN)":[153],"with":[154],"global":[155],"2D":[156],"descriptors.":[157],"Both":[158],"correctly":[160],"classified":[161],"than":[163],"90%":[164],"active":[166],"inactive":[168],"training":[171],"prediction":[173],"sets.":[174],"also":[176],"extracted":[177],"substructural":[179],"patterns":[180],"could":[182],"be":[183],"responsible":[184],"activity/inactivity":[187],"molecules":[189],"suggested":[194],"new":[195],"molecular":[196],"entities":[197],"possible":[199],"versatile":[202]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}